A synthetic lethal approach targeting mutant isocitrate dehydrogenase in acute myeloid leukemia

Nat Med. 2015 Feb;21(2):113-4. doi: 10.1038/nm.3796.

¹ Department of Medicine (Oncology), Division of Hemato-Oncology; the Department of Developmental and Molecular Biology; the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research; and the Albert Einstein Cancer Center, Albert Einstein College of Medicine/Montefiore Medical Center, New York, New York, USA.
² Department of Cell Biology; the Department of Medicine (Oncology), Division of Hemato-Oncology; the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research; and the Albert Einstein Cancer Center, Albert Einstein College of Medicine/Montefiore Medical Center, New York, New York, USA.

No abstract available

Publication types